Ascletis Pharma Inc.

About Us
Corporate Overview Management Team Board of Directors Contact Us
Our Focus
Viral Diseases NASH Cancer Exploratory Indications
Products&Pipeline
Pipeline Products Clinical Trials
Partnership
Investors
Financials & Filing Presentation Materials
News
Careers

Investors

Financials & Filing
Presentation Materials

2024

2023

2022

2021

2020

2019

2018

2024
2023
2022
2021
2020
2019
2018

Next Day Disclosure Returns - Share Buyback
2023-10-17
Next Day Disclosure Returns - Share Buyback
2023-10-16
Next Day Disclosure Returns - Share Buyback
2023-10-12
Next Day Disclosure Returns - Share Buyback
2023-10-11
Voluntary Announcement - Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023
2023-10-11
Next Day Disclosure Returns - Share Buyback
2023-10-10
Next Day Disclosure Returns - Share Buyback
2023-10-09
Next Day Disclosure Returns - Share Buyback
2023-10-06
Next Day Disclosure Returns - Share Buyback
2023-10-05
Next Day Disclosure Returns - Share Buyback
2023-10-04

6

© 2018 Ascletis Pharma Inc.

All Rights Reserved

contact

pr@ascletis.com
bd@ascletis.com

hr@ascletis.com
clinicaltrials@ascletis.com

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1